Mounjaro and Fertility in Men: What the Evidence Actually Says

You're weighing up Mounjaro while trying for a baby (here's where the science stands

Picture this: you've been researching Mounjaro, you know it's clinically supported for weight management, and then a question surfaces) what does it do to male fertility? It's a reasonable thing to want answered properly, not brushed aside.

The truthful position is that no published human trial has been designed specifically to measure tirzepatide's effect on sperm count, motility, morphology or male reproductive hormones. The pre-clinical (animal) studies submitted as part of the regulatory process found no evidence of harm to male reproductive organs or fertility at doses relevant to human treatment, which is why the Mounjaro prescribing information does not flag male fertility as a known concern. That said, absence of a specific signal in animal data is not the same as a clean bill of health for humans, the research simply hasn't been done yet at the scale needed to be definitive. You can read the full prescribing information via the Mounjaro SmPC on the eMC, which sets out what the evidence base covers and where gaps remain.

What we do have is a growing body of evidence around obesity, metabolic health and male fertility more broadly. The NHS tirzepatide page provides a patient-level overview of how the medicine works and what it's used for, which is a sensible starting point alongside your own prescriber's guidance.

How obesity itself affects male fertility, and why weight loss can change things

This is where the picture gets more nuanced, and arguably more hopeful. Obesity in men is independently associated with lower testosterone levels, elevated oestrogen (because fat tissue converts androgens), reduced sperm quality and a higher rate of DNA fragmentation in sperm. None of that is inevitable or irreversible, but it is real, and it's why some fertility specialists now consider weight management part of the conversation for couples trying to conceive.

If Mounjaro helps a man lose a clinically meaningful amount of weight (as it did for many participants across the SURMOUNT clinical programme) the downstream effects on hormonal balance and reproductive health could, in principle, be positive. Several smaller studies of weight loss interventions in men with obesity have shown improvements in testosterone and semen parameters. Mounjaro hasn't been studied for this specific outcome, but the metabolic changes it drives are consistent with those that appear to benefit male fertility in the broader literature. This is discussed in more depth on our male fertility and Mounjaro page.

The uncertainty cuts both ways. We don't have human data confirming benefit, and we don't have data confirming harm. That's why this decision needs to be a conversation, not a calculation you make alone based on what's available online.

Practical steps if you're actively trying to conceive

If conception is an active goal right now, there are a few things worth doing before or alongside starting Mounjaro. First, raise it explicitly with your prescriber, not as an afterthought at the end of the consultation, but as a central part of it. A prescriber who knows you're trying for a child can weigh that context alongside everything else.

Second, if you or your partner have had any fertility investigations or are under a specialist, loop them in. Male fertility is affected by multiple variables (age, lifestyle, underlying conditions, previous treatments) and tirzepatide is one more variable your care team should know about. NHS England's guidance on weight-management injections, available at NHS England's weight-management injections page, covers the broader context of how these medicines interact with other aspects of health.

Third, if you're curious about how Mounjaro compares to the broader category of GLP-1 treatments and what the fertility evidence looks like across that group, our tirzepatide and fertility overview covers the wider picture. For questions specific to female partners taking Mounjaro, our page on Mounjaro and fertility addresses the full picture of how this medicine intersects with reproductive health, including considerations for women, separately covered on the women's fertility page.

At nume, every consultation is reviewed personally by a GPhC-registered Independent Prescriber, a real clinician reads your answers on the same day. If you order before 12pm on a weekday and are clinically approved, your treatment is dispatched that day; it arrives the next working day via DPD in plain, unbranded packaging with tracking on your phone. But for a situation like this, the value isn't in the speed of delivery, it's in starting that clinical conversation properly. Speak to our prescribers about your specific situation.

What we don't yet know, and why it's worth staying informed

Reproductive medicine is an area where the GLP-1 evidence base is genuinely still developing. Studies looking specifically at tirzepatide's effects on human spermatogenesis, luteinising hormone, follicle-stimulating hormone and testosterone are not yet published at the scale needed for firm conclusions. This isn't unusual for a relatively new medicine, the gap between approval and long-term reproductive data takes years to close.

The MHRA and prescribers monitor emerging safety signals through ongoing pharmacovigilance. If you experience anything unexpected (changes in libido, testicular discomfort, or anything you're uncertain about) report it via the MHRA Yellow Card scheme and speak to your prescriber. That reporting pipeline is how the evidence base gets built.

For a broader look at what's known about Mounjaro's effects on fertility across all the available evidence, our Mounjaro and fertility overview brings together the key points. And if you want to understand the treatment itself before deciding whether to proceed, the Mounjaro treatment guide covers mechanism, eligibility and what treatment involves in full.